Inventor
YongQi Mu
Inventor
Los Altos, CA, US
Overview
Patents· 92 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes18%
C07KPeptides5%
B82YSpecific uses or applications of nanostructures3%
C07CAcyclic or carbocyclic compounds3%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds1%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds0%
C08LCompositions of macromolecular compounds0%
PatentTitleYear
10,844,076Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine202010,766,845Fluorination of acrylate esters and derivatives202010,766,864Morphinan derivatives for the treatment of neuropathic pain202010,584,089Fluorination of acrylate esters and derivatives202010,570,092Biphenyl compounds useful as muscarinic receptor antagonists202010,343,995Biphenyl compounds useful as muscarinic receptor antagonists201910,272,103Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants201910,189,859Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine201910,138,198Fluorination of acrylate esters and derivatives201810,106,503Biphenyl compounds useful as muscarinic receptor antagonists20189,926,272'Biphenyl compounds useful as muscarinic receptor antagonists'20189,738,584'Fluorination of acrylate esters and derivatives'20179,655,920'Amine polymers for use as bile acid sequestrants'20179,464,040'Fluorination of acrylate esters and derivatives'20169,452,161'Biphenyl compounds useful as muscarinic receptor antagonists'20169,283,183'Biphenyl compounds useful as muscarinic receptor antagonists'20169,216,971'Quaternary ammonium compounds useful as muscarinic receptor antagonists'20159,181,364'Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants'20159,061,990'Fluorination of acrylate esters and derivatives'20158,912,334'Biphenyl compounds useful as muscarinic receptor antagonists'20148,815,907'Quaternary ammonium compounds useful as muscarinic receptor antagonists'20148,802,856'Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists'20148,785,633'Guanidine-containing compounds useful as muscarinic receptor antagonists'20148,592,453'Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists'20138,557,997'Biphenyl compounds useful as muscarinic receptor antagonists'20138,501,776'Biphenyl compounds useful as muscarinic receptor antagonists'20138,492,407'Quaternary ammonium compounds useful as muscarinic receptor antagonists'20138,487,107'Biphenyl compounds useful as muscarinic receptor antagonists'20138,450,362'Amidine-containing compounds useful as muscarinic receptor antagonists'20138,399,488'Biphenyl compounds useful as muscarinic receptor antagonists'20138,378,121'Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists'20138,377,966'Biphenyl compounds useful as muscarinic receptor antagonists'20138,338,424'Guanidine-containing compounds useful as muscarinic receptor antagonists'20128,329,911'Biphenyl compounds useful as muscarinic receptor antagonists'20128,273,894'Biphenyl compounds useful as muscarinic receptor antagonists'20128,242,138'Amidine-containing compounds useful as muscarinic receptor antagonists'20128,211,915'Biphenyl compounds useful as muscarinic receptor antagonists'20128,202,891'Quaternary ammonium compounds useful as muscarinic receptor antagonists'20128,198,304'Guanidine-containing compounds useful as muscarinic receptor antagonists'20128,173,815'Biphenyl compounds useful as muscarinic receptor antagonists'20128,158,580'Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin'20128,133,905'Biphenyl compounds useful as muscarinic receptor antagonists'20128,124,627'Biphenyl compounds useful as muscarinic receptor antagonists'20128,119,796'Biphenyl compounds useful as muscarinic receptor antagonists'20128,067,439'Biphenyl compounds useful as muscarinic receptor antagonists'20118,053,448'Biphenyl compounds useful as muscarinic receptor antagonists'20118,039,489'Guanidine-containing compounds useful as muscarinic receptor antagonists'20118,034,946'Biphenyl compounds useful as muscarinic receptor antagonists'20118,017,617'Amidine-containing compounds useful as muscarinic receptor antagonists'20118,017,783'Biphenyl compounds useful as muscarinic receptor antagonists'20118,013,152'Biphenyl compounds useful as muscarinic receptor antagonists'20117,973,055'Crystalline forms of a biphenyl compound'20117,960,385'Guanidine-containing compounds useful as muscarinic receptor antagonists'20117,910,608'Biphenyl compounds useful as muscarinic receptor antagonists'20117,868,175'Biphenyl compounds useful as muscarinic receptor antagonists'20117,858,795'Biphenyl compounds useful as muscarinic receptor antagonists'20107,858,792'Biphenyl compounds useful as muscarinic receptor antagonists'20107,858,797'Biphenyl compounds useful as muscarinic receptor antagonists'20107,851,632'Biphenyl compounds useful as muscarinic receptor antagonists'20107,851,631'Biphenyl compounds useful as muscarinic receptor antagonists'20107,834,185'Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists'20107,816,532'Biphenyl compounds useful as muscarinic receptor antagonists'20107,803,812'Biphenyl compounds useful as muscarinic receptor antagonists'20107,728,144'Biphenyl compounds useful as muscarinic receptor antagonists'20107,723,470'Glycopeptide derivatives and pharmaceutical compositions containing the same'20107,687,519'Biphenyl compounds useful as muscarinic receptor antagonists'20107,683,173'Biphenyl compounds useful as muscarinic receptor antagonists'20107,659,403'Biphenyl compounds useful as muscarinic receptor antagonists'20107,642,355'Biphenyl compounds useful as muscarinic receptor antagonists'20107,632,847'Biphenyl compounds useful as muscarinic receptor antagonists'20097,629,336'Biphenyl compounds useful as muscarinic receptor antagonists'20097,585,879'Biphenyl compounds useful as muscarinic receptor antagonists'20097,569,588'Biphenyl compounds useful as muscarinic receptor antagonists'20097,560,469'Biphenyl compounds useful as muscarinic receptor antagonists'20097,550,595'Biphenyl compounds useful as muscarinic receptor antagonists'20097,544,364'Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin'20097,524,962'Biphenyl compounds useful as muscarinic receptor antagonists'20097,521,041'Biphenyl compounds useful as muscarinic receptor antagonists'20097,491,736'Biphenyl compounds useful as muscarinic receptor antagonists'20097,479,562'Biphenyl compounds useful as muscarinic receptor antagonists'20097,456,199'Biphenyl compounds useful as muscarinic receptor antagonists'20087,288,657'Biphenyl compounds useful as muscarinic receptor antagonists'20077,265,133'Biphenyl compounds useful as muscarinic receptor antagonists'20077,262,205'Biphenyl compounds useful as muscarinic receptor antagonists'20077,067,483'Pharmaceutical compositions containing a gycopeptide antibiotic and a cyclodextrin'20067,026,288'Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin'20066,962,970'Glycopeptide derivatives and pharmaceutical compositions containing the same'20056,872,804'Glycopeptide disulfide and thioester derivatives'20056,858,584'Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin'20056,455,669'Glycopeptide derivatives and pharmaceutical compositions containing the same'20026,444,786'Glycopeptide derivatives and pharmaceutical compositions containing the same'20026,392,012'Glycopeptide derivatives and pharmaceutical compositions containing the same'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2013Patents assigned to THERAVANCE INC (67)· patent assignee history
2002–2020Based in Los Altos, CA, US· patent location history
2011–2017Patents assigned to MU YONGQI (32)· patent assignee history
2011–2016Patents assigned to JI YUHUA (28)· patent assignee history
2011–2016Patents assigned to HUSFELD CRAIG (22)· patent assignee history
2012–2016Patents assigned to LI LI (16)· patent assignee history
2013Based in Los Alto, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| THERAVANCE INC | 67 | 2002–2013 |
| MU YONGQIself | 32 | 2011–2017 |
| JI YUHUA | 28 | 2011–2016 |
| HUSFELD CRAIG | 22 | 2011–2016 |
| LI LI | 16 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Los Altos, California, US | 91 | 2002–2020 |
| Los Alto, California, US | 1 | 2013 |